Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study.

IF 4.8 2区医学 Q1 CLINICAL NEUROLOGY

Journal of Neurology Pub Date : 2025-05-27 DOI:10.1007/s00415-025-13108-x

Ferdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, Melissa Sorosina, Alen Zollo, Fredrik Piehl, Tomas Olsson, Pernilla Stridh, Maja Jagodic, Bernhard Hemmer, Christiane Gasperi, Adil Harroud, Klementy Shchetynsky, Alessandra Mingione, Elisabetta Mascia, Kaalindi Misra, Antonino Giordano, Maria Laura Terzi Mazzieri, Alberto Priori, Janna Saarela, Ingrid Kockum, Massimo Filippi, Federica Esposito, Filippo Martinelli Boneschi

引用次数: 0

查看原文本刊更多论文

纠正：药物基因组学对多发性硬化症纳他珠单抗的临床反应：一项全基因组多中心关联研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Neurology 医学-临床神经学

CiteScore

10.00

自引率

5.00%

发文量

558

审稿时长

1 months

期刊介绍： The Journal of Neurology is an international peer-reviewed journal which provides a source for publishing original communications and reviews on clinical neurology covering the whole field. In addition, Letters to the Editors serve as a forum for clinical cases and the exchange of ideas which highlight important new findings. A section on Neurological progress serves to summarise the major findings in certain fields of neurology. Commentaries on new developments in clinical neuroscience, which may be commissioned or submitted, are published as editorials. Every neurologist interested in the current diagnosis and treatment of neurological disorders needs access to the information contained in this valuable journal.